title: Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease.
abstract: To dissect the individual effects of the four non-MHC, autosomal loci (Bxs1 to Bxs4) that contribute to SLE susceptibility in BXSB mice, we generated congenic lines from chromosome 1 on a C57BL/10.Y(BXSB) (B10.Yaa) background for the intervals (values in megabases (Mb)) Bxs1 (46.3-89.2 Mb), Bxs1/4 (20.0-65.9 Mb), Bxs1/2 (64.4-159.0 Mb), and Bxs2/3 (105.4-189.0 Mb). Glomerulonephritis, qualitatively similar to that seen in the parental BXSB strain, developed in three of these congenic strains. Early onset, severe disease was observed in B10.Yaa.BXSB-Bxs2/3 congenic mice and caused 50% mortality by 12 mo. In B10.Yaa.BXSB-Bxs1/4 mice disease progressed more slowly, resulting in 13% mortality at 12 mo. The progression of renal disease in both of these strains was correlated with the level of anti-dsDNA Abs. B10.Yaa.BXSB-Bxs1 mice, despite their genetic similarity to B10.Yaa.BXSB-Bxs1/4 mice, developed a low-grade glomerulonephritis in the absence of anti-dsDNA Abs. Thus, Bxs4 directed an increase in titer and spectrum of autoantibodies, whereas Bxs1 promoted the development of nephritis. The Bxs2 interval was linked to the production of anti-dsDNA Abs without concomitant glomerulonephritis. In contrast, the Bxs3 interval was sufficient to generate classic lupus nephritis in a nonautoimmune-prone strain. Immune phenotype differed between controls and congenics with a significant increase in B220(+) cells in BXSB and B10.Yaa.BXSB-Bxs2/3, and an increase in CD4 to CD8 ratio in both BXSB and B10.Yaa.BXSB-Bxs1/4. Disease in the Bxs3 mice was delayed in comparison to the BXSB parental strain, emphasizing the necessity for multiple interactions in the production of the full BXSB phenotype.
authors.affiliation: Rheumatology Section, Eric Bywaters Centre, Faculty of Medicine, Imperial College, London, UK.
authors.forename: Michelle E K
authors.initials: ME
authors.lastname: Haywood
authors.forename: Nicola J
authors.initials: NJ
authors.lastname: Rogers
authors.forename: S Jane
authors.initials: SJ
authors.lastname: Rose
authors.forename: Joseph
authors.initials: J
authors.lastname: Boyle
authors.forename: Aileen
authors.initials: A
authors.lastname: McDermott
authors.forename: Joanna M
authors.initials: JM
authors.lastname: Rankin
authors.forename: Vasuky
authors.initials: V
authors.lastname: Thiruudaian
authors.forename: Margarita R
authors.initials: MR
authors.lastname: Lewis
authors.forename: Liliane
authors.initials: L
authors.lastname: Fossati-Jimack
authors.forename: Shozo
authors.initials: S
authors.lastname: Izui
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Walport
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Morley
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000096:biosynthesis; D002874:Chromosome Mapping; D003433:Crosses, Genetic; D005260:Female; D008040:Genetic Linkage; D005819:Genetic Markers / Q000276:immunology; D020022:Genetic Predisposition to Disease; D016130:Immunophenotyping; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology* / Q000401:mortality; D008181:Lupus Nephritis / Q000235:genetics / Q000276:immunology; D008297:Male; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D010641:Phenotype; D012720:Severity of Illness Index; D013163:Splenomegaly / Q000235:genetics / Q000276:immunology
chemical_list: D001323:Autoantibodies; D005819:Genetic Markers